Paul Scrivano, who a year ago took over as global head of M&A and private equity at O’Melveny & Myers, has left the firm for Ropes & Gray.
The Boston-based Am Law 100 firm, known for its corporate strength in advising private equity sponsors and key strategic acquirers in the pharmaceuticals sector like Pfizer Inc. and Shire Pharmaceuticals LLC, will see Scrivano become its new global head of M&A.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
